Big Pharma is using dark money to fund groups that sound like patient advocacy organizations but represent the industry.

March 3, 2020, Paper: "Some of the most valuable innovations known to medicine have come from the pharmaceutical industry. Yet, the cost of those innovations places new drugs out of reach for many ...

about how the political landscape may impact the pharmaceutical industry. The fundamentals of healthcare are established and supported in the United States, Alexander Seyf, CEO and co-founder of ...

If two “End the Pill Penalty” flyers have reached my dusty rural mailbox, chances are many Minnesotans have received these Big Pharma-friendly missives, too. The flyers almost got tossed with ...

Hyderabad: Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Eugia PharmaSpecialities Limited, has received final approval from the US Food & Drug Administration (USFDA) to ...

Boehringer Ingelheim has signed a €500m ($572m) agreement with UK-based biotech Tessellate Bio to co-develop targeted cancer therapies for tumours that rely on the alternative lengthening of ...

The PharmTech Group interviewed Edwin Stone, CEO of Cellular Origins, about the impact of the changing political landscape on the pharmaceutical industry. The political landscape is evolving and ...

In his view, the U.S. trade imbalance with Ireland — one largely driven by pharmaceutical exports — is a particular injustice. As a result, the industry is now caught in his crosshairs ...

While Washington has placed India in the 26 per cent reciprocal tariff category, pharmaceuticals have been kept off that basket. However, the industry may see a 10 per cent tariff or none given the ...